Monovalent, bivalent and trivalent anti human respiratory syncytial virus (hRSV) nanobody constructs for the prevention and/or treatment of respiratory tract infections
Details for Australian Patent Application No. 2010255638 (hide)
International Classifications
Event Publications
12 January 2012 PCT application entered the National Phase
PCT publication WO2010/139808 Priority application(s): WO2010/139808
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2010255639-Reduction of in vitro genotoxicity of pollen extracts by removal of flavonoids
2010255615-Powder-actuated tool, in particular for underwater work
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
- Editable Word format reports
- For IP Professionals
- Multiuser